Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC

Authors:

Neal D.Shore, Kamat M.Ashish, Hahn Noah, Alanee Shaheen, Nishiyama Hiroyuki, Shariat Shahrokh, Nam Kijoeng, Kapadia Ekta, Frenkl Tara, Steinberg Gary,

Journal

Future Oncol

Year

2020

Volume

Apr

Pages

507-516

Physicians